Skip to main content
. 2015 Feb 3;7(1):5. doi: 10.1186/s13195-014-0081-2

Figure 5.

Figure 5

Mean change in NPI-2 from baseline (FAS). NPI, Neuropsychiatric Inventory; FAS, full analysis set. (a)PLA-DON10 group started treatment with 3 mg at Week 16, and the dose was increased to 5 mg at Week 18. (b)PLA-DON10 and DON5-DON10 groups started treatment with 10 mg at Week 24 (dose decrease to 5 mg was allowed). *P < 0.05 (paired t test).